Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ISABEL MENDOZA

Allopathic & Osteopathic Physicians Family Medicine

NPI
1336286475
CMS profile
1170147
Location
DARLINGTON, SC

General Payments · PY2018–2024

$1,164.56

  • Reported across 68 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$290.77

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $290.77 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $90.47 6
PY2019 $72.62 2
PY2020 $91.50 6
PY2021 $295.11 19
PY2022 $224.10 14
PY2023 $99.99 5
PY2024 $290.77 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $14.34 01/08/2024 Food and Beverage Undisputed 01/23/2026 1117326756 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.76 06/03/2024 Food and Beverage Undisputed 01/23/2026 1086106964 CMS
Boston Scientific Corporation $17.64 06/10/2024 Food and Beverage Undisputed 01/23/2026 1092381620 CMS
Insulet Corporation $24.88 11/20/2024 Food and Beverage Undisputed 01/23/2026 1116826644 CMS
Lilly USA, LLC $13.13 03/22/2024 Food and Beverage Undisputed 01/23/2026 1135029584 CMS
Novartis Pharmaceuticals Corporation $15.58 02/20/2024 Food and Beverage Undisputed 01/23/2026 1087132828 CMS
Novartis Pharmaceuticals Corporation $14.32 06/11/2024 Food and Beverage Undisputed 01/23/2026 1087132844 CMS
Novartis Pharmaceuticals Corporation $23.24 10/07/2024 Food and Beverage Undisputed 01/23/2026 1087132864 CMS
Novartis Pharmaceuticals Corporation $27.24 12/11/2024 Food and Beverage Undisputed 01/23/2026 1087132872 CMS
Novo Nordisk Inc $13.17 01/30/2024 Food and Beverage Undisputed 01/23/2026 1096561919 CMS
Novo Nordisk Inc $23.80 10/01/2024 Food and Beverage Undisputed 01/23/2026 1096563333 CMS
Novo Nordisk Inc $19.92 11/05/2024 Food and Beverage Undisputed 01/23/2026 1096565037 CMS
PFIZER INC. $19.37 05/08/2024 Food and Beverage Undisputed 01/23/2026 1132036102 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.39 11/13/2024 Food and Beverage Undisputed 01/23/2026 1153509879 CMS
SHIELD THERAPEUTICS INC $15.78 11/18/2024 Food and Beverage Undisputed 01/23/2026 1150154602 CMS
Xeris Pharmaceuticals, Inc. $18.21 04/09/2024 Food and Beverage Undisputed 01/23/2026 1144597010 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.